MedPath

Effects of laser on preventing decreased sensitivity in women with breast cancer during chemotherapy

Phase 3
Recruiting
Conditions
Tactile Perception
F02.463.593.894
Registration Number
RBR-9wsg72
Lead Sponsor
niversidade Federal de Minas Gerais
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Pathologic anatomic report of cancer;
Beginning of treatment with antineoplastic chemotherapy containing taxanes, platines, vinca alkaloids and bortezomib alone or in combination;
Absence of PSTA, identified by symptom reporting and stoichiometry test;
Adults above 18 years.

Exclusion Criteria

Hoseniasis;
Diabetes melittus;
Cognitive deficits;
Other neuropathies, including those caused by tumor infiltration;
Absence of verbalization;
Pregnant;
Performance Status greater than or equal to 3;
Acupuncture in the last 6 months for neuropathy;
Alcoholism;
Skin problems in the irradiated area;
Presence of the tumor at the irradiation sites.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is expected that the difference between the groups for tactile sensory perception is up to 30% by the stoichiometry and questionnaire of neuropathy induced by chemotherapy<br><br>
Secondary Outcome Measures
NameTimeMethod
Differences between groups for neuropathic pain are expected to be up to 5% for the neuropathic pain questionnaire Douleur neuropathique 4 questions;It is expected that the difference between the groups for anxiety is up to 60% for the Anxiety and Depression Scale (HADS);The difference between the groups for depression is expected to improve by up to 30% for the anxiety and depression questionnaire (Hospital Anxiety and Depression Scale - HADS);The difference between the groups for quality of life is expected to be up to 70% by the Functional Assessment of Cancer Therapy / Neurotoxicity (FACT / GOG-NTx)
© Copyright 2025. All Rights Reserved by MedPath